ACADIA PHARMACEUTICALS INC. Deferred Compensation Arrangement with Individual, Employer Contribution (Deprecated 2017-01-31)
ACADIA PHARMACEUTICALS INC. (ACAD) reported Deferred Compensation Arrangement with Individual, Employer Contribution (Deprecated 2017-01-31) of $240.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualEmployerContribution · last filed 2014-02-27
- ACADIA PHARMACEUTICALS INC. deferred compensation arrangement with individual, employer contribution (deprecated 2017-01-31) for fiscal 2013 was $240.00K, a 33.33% increase from fiscal 2012.
- ACADIA PHARMACEUTICALS INC. deferred compensation arrangement with individual, employer contribution (deprecated 2017-01-31) for fiscal 2012 was $180.00K, a 15.38% increase from fiscal 2011.
- ACADIA PHARMACEUTICALS INC. deferred compensation arrangement with individual, employer contribution (deprecated 2017-01-31) for fiscal 2011 was $156.00K, a 17.29% increase from fiscal 2010.
- ACADIA PHARMACEUTICALS INC. deferred compensation arrangement with individual, employer contribution (deprecated 2017-01-31) for fiscal 2010 was $133.00K.
| Period end | Deferred Compensation Arrangement with Individual, Employer Contribution (Deprecated 2017-01-31) 12 month |
|---|---|
| 2013-12-31 | $240.00K 10-K · filed 2014-02-27 |
| 2012-12-31 | $180.00K 10-K · filed 2014-02-27 |
| 2011-12-31 | $156.00K 10-K · filed 2014-02-27 |
| 2010-12-31 | $133.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |